Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials
NEW YORK--(BUSINESS WIRE)--#biotech--Koneksa, the evidence-based digital biomarkers company, announced today an extended partnership with SSI Strategy, a life sciences consulting firm, that will provide both organizations with expanded client service o...